Literature DB >> 18541617

Effects of prenatal cocaine exposure on special education in school-aged children.

Todd P Levine1, Jing Liu, Abhik Das, Barry Lester, Linda Lagasse, Seetha Shankaran, Henrietta S Bada, Charles R Bauer, Rosemary Higgins.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the effects of prenatal cocaine exposure on special education at age 7 with adjustment for covariates.
METHODS: As part of the prospective, longitudinal, multisite study of children with prenatal cocaine exposure (Maternal Lifestyle Study), school records were reviewed for 943 children at 7 years to determine involvement in special education outcomes: (1) individualized education plan; (2) special education conditions; (3) support services; (4) special education classes; and (5) speech and language services. Logistic regression was used to examine the effect of prenatal cocaine exposure on these outcomes with environmental, maternal, and infant medical variables as covariates, as well as with and without low child IQ.
RESULTS: Complete data for each analysis model were available for 737 to 916 children. When controlling for covariates including low child IQ, prenatal cocaine exposure had a significant effect on individualized education plan. When low child IQ was not included in the model, prenatal cocaine exposure had a significant effect on support services. Male gender, low birth weight, white race, and low child IQ also predicted individualized education plan. Low birth weight and low child IQ were significant in all models. White race was also significant in speech and language services. Other covariate effects were model specific. When included in the models, low child IQ accounted for more of the variance and changed the significance of other covariates.
CONCLUSIONS: Prenatal cocaine exposure increased the likelihood of receiving an individualized education plan and support services, with adjustment for covariates. Low birth weight and low child IQ increased the likelihood of all outcomes. The finding that white children were more likely to get an individualized education plan and speech and language services could indicate a greater advantage in getting educational resources for this population.

Entities:  

Mesh:

Year:  2008        PMID: 18541617      PMCID: PMC2861352          DOI: 10.1542/peds.2007-2826

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  52 in total

1.  The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.

Authors:  B M Lester; M ElSohly; L L Wright; V L Smeriglio; J Verter; C R Bauer; S Shankaran; H S Bada; H H Walls; M A Huestis; L P Finnegan; P L Maza
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

2.  Twelve-year follow-up of children exposed to alcohol in utero.

Authors:  I Autti-Rämö
Journal:  Dev Med Child Neurol       Date:  2000-06       Impact factor: 5.449

3.  Acute neonatal effects of cocaine exposure during pregnancy.

Authors:  Charles R Bauer; John C Langer; Seetha Shankaran; Henrietta S Bada; Barry Lester; Linda L Wright; Heidi Krause-Steinrauf; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza; Joel Verter
Journal:  Arch Pediatr Adolesc Med       Date:  2005-09

4.  Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome.

Authors:  Sandra W Jacobson; Lisa M Chiodo; Robert J Sokol; Joseph L Jacobson
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

5.  Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure.

Authors:  E S Bandstra; C E Morrow; J C Anthony; V H Accornero; P A Fried
Journal:  Neurotoxicol Teratol       Date:  2001 Nov-Dec       Impact factor: 3.763

6.  Prenatal drug exposure and selective attention in preschoolers.

Authors:  Julia S Noland; Lynn T Singer; Elizabeth J Short; Sonia Minnes; Robert E Arendt; H Lester Kirchner; Cynthia Bearer
Journal:  Neurotoxicol Teratol       Date:  2005-03-29       Impact factor: 3.763

7.  Gender and alcohol moderate prenatal cocaine effects on teacher-report of child behavior.

Authors:  Beth Nordstrom Bailey; Beena G Sood; Robert J Sokol; Joel Ager; James Janisse; John H Hannigan; Chandice Covington; Virginia Delaney-Black
Journal:  Neurotoxicol Teratol       Date:  2004-11-24       Impact factor: 3.763

Review 8.  Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.

Authors:  D A Frank; M Augustyn; W G Knight; T Pell; B Zuckerman
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

9.  The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes.

Authors:  Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Barry Lester; Linda L Wright; Heidi Krause-Steinrauf; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza; Joel Verter
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

10.  Teacher-assessed behavior of children prenatally exposed to cocaine.

Authors:  V Delaney-Black; C Covington; T Templin; J Ager; B Nordstrom-Klee; S Martier; L Leddick; R H Czerwinski; R J Sokol
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

View more
  20 in total

1.  Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.

Authors:  Katherine Tassiopoulos; Jennifer S Read; Susan Brogly; Kenneth Rich; Barry Lester; Stephen A Spector; Ram Yogev; George R Seage
Journal:  AIDS Behav       Date:  2010-12

Review 2.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

3.  Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Authors:  Kathryn Rough; Katherine Tassiopoulos; Deborah Kacanek; Raymond Griner; Ram Yogev; Kenneth C Rich; George R Seage
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

Review 4.  Prenatal substance abuse: short- and long-term effects on the exposed fetus.

Authors:  Marylou Behnke; Vincent C Smith
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

Review 5.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

6.  Cognitive and behavioral outcomes after early exposure to anesthesia and surgery.

Authors:  Randall P Flick; Slavica K Katusic; Robert C Colligan; Robert T Wilder; Robert G Voigt; Michael D Olson; Juraj Sprung; Amy L Weaver; Darrell R Schroeder; David O Warner
Journal:  Pediatrics       Date:  2011-10-03       Impact factor: 7.124

7.  Prenatal substance exposure: neurobiologic organization at 1 month.

Authors:  Elisabeth Conradt; Stephen J Sheinkopf; Barry M Lester; Ed Tronick; Linda L LaGasse; Seetha Shankaran; Henrietta Bada; Charles R Bauer; Toni M Whitaker; Jane A Hammond
Journal:  J Pediatr       Date:  2013-06-04       Impact factor: 4.406

8.  Adolescents with and without gestational cocaine exposure: Longitudinal analysis of inhibitory control, memory and receptive language.

Authors:  Laura M Betancourt; Wei Yang; Nancy L Brodsky; Paul R Gallagher; Elsa K Malmud; Joan M Giannetta; Martha J Farah; Hallam Hurt
Journal:  Neurotoxicol Teratol       Date:  2011 Jan-Feb       Impact factor: 3.763

Review 9.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

10.  Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco.

Authors:  Jie Liu; Barry M Lester; Nurunisa Neyzi; Stephen J Sheinkopf; Luis Gracia; Minal Kekatpure; Barry E Kosofsky
Journal:  JAMA Pediatr       Date:  2013-04       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.